|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 5/0783 | (2010.01) |
| C12N2501/39 | (2013.01) | ||
| A61K 38/00 | (2006.01) | ||
| C12N2501/51 | (2013.01) | ||
| A61K 35/17 | (2015.01) | ||
| C12N2501/515 | (2013.01) | ||
| C07K 14/725 | (2006.01) | ||
| C12N2501/599 | (2013.01) | ||
| C07K 14/705 | (2006.01) | ||
| C12N2502/99 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| C07K 14/70517 | (2013.01) | ||
| C07K 14/70578 | (2013.01) | ||
| C07K2319/00 | (2013.01) | ||
| C07K 14/7051 | (2013.01) | ||
| C07K 16/28 | (2013.01) | ||
| C07K2317/569 | (2013.01) | ||
| C12N2510/00 | (2013.01) | ||
| C07K 16/2803 | (2013.01) | ||
| A61K 38/00 | (2013.01) | ||
| C07K 14/70521 | (2013.01) | ||
| C07K2319/03 | (2013.01) | ||
| C12N 5/0636 | (2013.01) | ||
| A61P 21/00 | (2018.01) | ||
| A61P 31/00 | (2018.01) | ||
| A61P 31/12 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 37/02 | (2018.01) | ||
| A61P 37/04 | (2018.01) | ||
| A61P 37/06 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 5/38 | (2018.01) | ||
| A61K 39/464412 | (2023.05) | ||
| A61K 39/4611 | (2023.05) | ||
| A61K 39/4631 | (2023.05) |
| (11) | Number of the document | 3473707 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18210258.2 |
| Date of filing the European patent application | 2013-05-13 | |
| (97) | Date of publication of the European application | 2019-04-24 |
| (45) | Date of publication and mention of the grant of the patent | 2024-12-18 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201261651933 P | 2012-05-25 | US | |
| 201261696612 P | 2012-09-04 | US |
| (72) |
GALETTO, Roman , FR
GOUBLE, Agnes , FR
GROSSE, Stephanie , FR
MANNIOUI, Cécile , FR
POIROT, Laurent , FR
SCHARENBERG, Andrew , US
SMITH, Julianne , US
|
| (73) |
Cellectis ,
8 rue de la Croix Jarry, 75013 Paris,
FR
|
| (54) | METHODS FOR ENGINEERING ALLOGENEIC AND IMMUNOSUPPRESSIVE RESISTANT T CELL FOR IMMUNOTHERAPY |
| METHODS FOR ENGINEERING ALLOGENEIC AND IMMUNOSUPPRESSIVE RESISTANT T CELL FOR IMMUNOTHERAPY |